STRS Ohio’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,500
| Closed | -$983K | – | 2192 |
|
|
2019
Q3 | $983K | Sell |
14,500
-2,300
| -14% | -$158K | ﹤0.01% | 817 |
|
|
2019
Q2 | $977K | Buy |
16,800
+3,900
| +30% | +$231K | ﹤0.01% | 840 |
|
|
2019
Q1 | $903K | Sell |
12,900
-300
| -2% | -$22.2K | ﹤0.01% | 872 |
|
|
2018
Q4 | $850K | Sell |
13,200
-1,400
| -10% | -$98.1K | ﹤0.01% | 855 |
|
|
2018
Q3 | $1.02M | Sell |
14,600
-4,700
| -24% | -$275K | ﹤0.01% | 863 |
|
|
2018
Q2 | $972K | Sell |
19,300
-5,500
| -22% | -$218K | ﹤0.01% | 907 |
|
|
2018
Q1 | $775K | Sell |
24,800
-700
| -3% | -$23.2K | ﹤0.01% | 1034 |
|
|
2017
Q4 | $872K | Buy |
25,500
+1,200
| +5% | +$38.3K | ﹤0.01% | 933 |
|
|
2017
Q3 | $779K | Buy |
24,300
+1,800
| +8% | +$56.8K | ﹤0.01% | 1047 |
|
|
2017
Q2 | $732K | Sell |
22,500
-500
| -2% | -$15.8K | ﹤0.01% | 1050 |
|
|
2017
Q1 | $724K | Sell |
23,000
-1,500
| -6% | -$44.4K | ﹤0.01% | 1057 |
|
|
2016
Q4 | $720K | Sell |
24,500
-400
| -2% | -$12.2K | ﹤0.01% | 1088 |
|
|
2016
Q3 | $720K | Sell |
24,900
-2,500
| -9% | -$69.7K | ﹤0.01% | 1020 |
|
|
2016
Q2 | $709K | Hold |
27,400
| – | – | ﹤0.01% | 1034 |
|
|
2016
Q1 | $678K | Buy |
27,400
+3,000
| +12% | +$82.3K | ﹤0.01% | 1031 |
|
|
2015
Q4 | $858K | Sell |
24,400
-6,100
| -20% | -$163K | ﹤0.01% | 897 |
|
|
2015
Q3 | $645K | Buy |
30,500
+2,700
| +10% | +$69.6K | ﹤0.01% | 1115 |
|
|
2015
Q2 | $772K | Buy |
27,800
+2,000
| +8% | +$56.4K | ﹤0.01% | 1058 |
|
|
2015
Q1 | $788K | Buy |
25,800
+700
| +3% | +$22.3K | ﹤0.01% | 936 |
|
|
2014
Q4 | $802K | Hold |
25,100
| – | – | ﹤0.01% | 917 |
|
|
2014
Q3 | $711K | Sell |
25,100
-2,500
| -9% | -$69.7K | ﹤0.01% | 944 |
|
|
2014
Q2 | $756K | Sell |
27,600
-800
| -3% | -$21.3K | ﹤0.01% | 969 |
|
|
2014
Q1 | $748K | Buy |
28,400
+1,100
| +4% | +$31.6K | ﹤0.01% | 912 |
|
|
2013
Q4 | $799K | Sell |
27,300
-3,100
| -10% | -$98.4K | ﹤0.01% | 911 |
|
|
2013
Q3 | $930K | Buy |
30,400
+3,700
| +14% | +$124K | ﹤0.01% | 881 |
|
|
2013
Q2 | $847K | Buy |
+26,700
| New | +$877K | ﹤0.01% | 973 |
|
STRS Ohio's GHDX Position: Q4 2019 in Review
STRS Ohio sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 14,500 shares — an estimated $983K sold.
STRS Ohio first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $1.02M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- STRS Ohio reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- STRS Ohio sold 14,500 Genomic Health, Inc. shares in Q4 2019, an estimated $983K.
- STRS Ohio first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- STRS Ohio's Genomic Health, Inc. position peaked at $1.02M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on STRS Ohio's 13F filing for Q4 2019, filed 24 Jan 2020.